Author:
Zhang Xueju,Liu Weiwei,Zan Jie,Wu Chuanbin,Tan Wen
Abstract
AbstractAlzheimer’s Disease (AD) is closely connected to aberrant lipid metabolism. However, how early AD-like pathology synchronously influences brain and plasma lipidome in AD mice remains unclear. The study of dynamic change of lipidome in early-stage AD mice could be of great interest for the discovery of lipid biomarkers for diagnosis and monitoring of early-stage AD. For the purpose, an untargeted lipidomic strategy was developed for the characterization of lipids (≤ 1,200 Da) perturbation occurring in plasma and brain in early-stage AD mice (2, 3 and 7 months) by ultra-high performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Significant changes were detected in the levels of several lipid species including lysophospholipids, phosphatidylcholines (PCs), phosphatidylethanolamines (PEs) and Ceramides (Cers), as well as other related lipid compounds such as fatty acids (FAs), diacylglycerols (DGs) and triacylglycerols (TGs) in AD mice. In this sense, disorders of lipid metabolism appear to involve in multiple factors including overactivation of phospholipases and diacylglycerol lipases, decreased anabolism of lysophospholipids in plasma and PEs in plasma and brain, and imbalances in the levels of PCs, FAs and glycerides at different ages. We revealed the changing panels of potential lipid biomarkers with the development of early AD. The study raises the possibility of developing lipid biomarkers for diagnosis of early-stage AD.
Funder
China Postdoctoral Science Foundation Grant
2017 PhD Start-up Found of Guangdong Natural Science Foundation of China
Science and Technology Planning Project of Guangdong Province
National Science and Technology Major Projects for Major New Drugs Innovation and Development
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Patterson, C. World Alzheimer Report 2018: The state of the art of dementia research: New frontiers. Alzheimer's Disease International, London, 2018, https://www.alz.co.uk/research/world-report-2018.https://www.alz.co.uk/research/world-report-2018
2. Prince, M. et al. World Alzheimer Report 2014: World Alzheimer Report. Alzheimer's Disease International, London, 2014, https://www.alz.co.uk/research/world-report-2014.
3. Borchelt, D. R. et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939–945 (1997).
4. Joanna, L. J. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159–170 (2004).
5. Selkoe, D. J. Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766 (2001).
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献